{
  "fidelity_criteria": [
    {
      "criterion": "Reward for accurately documenting the patient's chief concern: worsening rheumatoid arthritis pain and worry that hydroxychloroquine may be insufficient",
      "weight": 15,
      "sense": "positive"
    },
    {
      "criterion": "Reward for capturing the patient's report of only slight, variable improvement since starting hydroxychloroquine",
      "weight": 10,
      "sense": "positive"
    },
    {
      "criterion": "Reward for noting that the patient takes folic acid daily and that a support group reinforces adherence",
      "weight": 10,
      "sense": "positive"
    },
    {
      "criterion": "Reward for recording the clinician's stated plan to give current therapy more time while monitoring closely and considering dose adjustment or alternative options if pain persists",
      "weight": 15,
      "sense": "positive"
    },
    {
      "criterion": "Penalize for omitting or inaccurately listing any of the current medications and their doses (Methotrexate 15 mg weekly, Hydroxychloroquine 200 mg daily, Folic acid 1 mg daily)",
      "weight": 20,
      "sense": "negative"
    },
    {
      "criterion": "Reward for including the documented allergy to sulfa drugs",
      "weight": 10,
      "sense": "positive"
    },
    {
      "criterion": "Penalize for adding symptoms, histories, or examination findings not present in the transcript or chart",
      "weight": 10,
      "sense": "negative"
    },
    {
      "criterion": "Reward for recording the patient's demographic information (55-year-old female)",
      "weight": 10,
      "sense": "positive"
    }
  ],
  "appropriateness_criteria": [
    {
      "criterion": "Reward for including a plan for regular laboratory monitoring (e.g., CBC, liver enzymes) appropriate for methotrexate therapy",
      "weight": 20,
      "sense": "positive"
    },
    {
      "criterion": "Reward for recommending baseline and periodic ophthalmologic screening due to hydroxychloroquine use",
      "weight": 15,
      "sense": "positive"
    },
    {
      "criterion": "Reward for reinforcing continued daily folic acid supplementation to mitigate methotrexate toxicity, demonstrating evidence-based counseling",
      "weight": 15,
      "sense": "positive"
    },
    {
      "criterion": "Penalize for failing to outline an evidence-based escalation strategy (dose adjustment or addition/change of DMARDs) if pain remains uncontrolled",
      "weight": 20,
      "sense": "negative"
    },
    {
      "criterion": "Penalize for proposing any medication dose increase or new therapy without an accompanying safety or monitoring plan",
      "weight": 15,
      "sense": "negative"
    }
  ]
}